The acrimonious dispute between Deloitte & Touche and Binder Hamlyn over unpaid fees for Deloittes’ #1m expert witness work during the ADT trial has been settled, a spokeswoman for Deloittes confirmed this week. The firms refused to comment on the settlement, but Accountancy Age understands Deloittes gave up its claim for full payment of the fees.
The numbers you crunch tell a story. Your expertis...
30yEmbracing user-friendly AP systems can turn the tide, streamlining workflows, enhancing compliance, and opening doors to early payment discounts. Read...
View articleOrganisations can enhance their financial operations' efficiency, accuracy, and responsiveness by adopting platforms that offer them self-service cust...
View articleIn a world of instant results and automated workloads, the potential for AP to drive insights and transform results is enormous. But, if you’re still ...
View resourceDiscover how AP dashboards can transform your business by enhancing efficiency and accuracy in tracking key metrics, as revealed by the latest insight...
View articleAs legacy payroll platforms reach end of life, accountancy firms are being forced into a strategic decision that goes far beyond software replacement....
View articleArtificial intelligence is no longer a futuristic concept but a present-day reality. As a result, the UK government is taking proactive steps to ensur...
View articleThe UK’s Pensions Regulator (TPR) has unveiled updated guidance for superfunds, introducing pivotal changes that accountants and financial plann...
View articleSue Perkins knows more than XBRL than expected. Xero’s CEO likes to get at least 80g of protein a day, which is hard since she’s a vegetar...
View articleDo your clients see you as an expense? In fact, do you see yourself as an expense to your clients? This shift requires a fundamental change in how acc...
View articleNearly eight in ten brokers (77%) believe that high street banks are scaling back their willingness to fund small and medium-sized businesses, accordi...
View articlePharma and life sciences companies should act now to prevent impact on drug production capabilities and business viability Read More...
View article476,000 UK SMEs will need an ESG plan in the next few years. Is your firm ready to support them? Read More...
View article